Anna Ferrari, MD, Professor and Co-Director GU Research at NYU Langone Medical Center, discusses the longstanding treatment options used in addition to chemotherapy, including antiadrogens and CYP inhibitors. Ketoconazole is an example of a CYP inhibitors.
Related ReadingCYP17 inhibitors for prostate cancer...